Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial sulfhydryl-containing enzymes and proteins represent a broad class of essential microbial molecules that serve as the primary targets for various antiseptic and disinfectant agents (Scribd, 2023; Thinkswap, 2023). These enzymes possess critical cysteine residues with free sulfhydryl (-SH) groups that are vital for their catalytic activity, structural integrity, and overall bacterial metabolism (Thinkswap, 2023). Antimicrobial agents, particularly heavy metals and organomercurial compounds like thimerosal and merbromin, exert their effects by binding to these sulfhydryl groups to form stable mercaptides (SelleckChem, 2022; NIH, 2023). This interaction leads to the non-specific inactivation of multiple enzymatic pathways, effectively disrupting key bacterial processes such as cellular respiration and DNA replication (Scribd, 2023; CDC, 2023). While highly effective as topical anti-infectives and preservatives, the therapeutic use of agents targeting these proteins is often limited by potential toxicity to host tissues and environmental concerns associated with heavy metal accumulation (FDA, 2025; ChemEurope, 2023).
Heavy metal ions or organomercurial compounds bind to the essential sulfhydryl (-SH) groups of bacterial enzymes, forming stable mercaptides that inactivate the enzymes and disrupt microbial metabolism (Scribd, 2023; NIH, 2023).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial sulfhydryl-containing enzymes and proteins.